Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Amplifon SpA is an Italian company and the world's largest retailer of hearing aids, specializing in the distribution and personalization of auditory devices and related services. Founded in 1950 in Milan, it leads the global hearing care retail market with a 13% market share, operating in 26 countries across Europe, Middle East, Africa (63.6% of sales), Americas (21%), and Asia-Pacific (15.4%). The company manages a vast network of approximately 10,000 outlets, including 5,480 owned stores, 1,210 franchises, and 3,310 shop-in-shops or corners, supported by over 20,900 employees, many of whom are specialized hearing care professionals. Its core activities focus on selling hearing aids under brands like Amplifon, Beter Horen, Miracle-Ear, and Sonus (86.8% of revenue), alongside services such as testing, fitting, and ongoing adjustments (13.2%). Amplifon emphasizes innovation through advanced technologies, personalized solutions, and long-term customer relationships, revolutionizing hearing care by helping millions rediscover the emotions of sound. With 2024 revenues exceeding 1.7 billion euros, it plays a pivotal role in the medical equipment and healthcare services sector, promoting inclusion and sustainability.
Operating margin is thin at 8.55%. Limited cushion if revenue slows or costs rise, not the profile of a wide-moat business.
Revenue declined 0.6% YoY. The question is whether this is cyclical or a structural shift.
Net debt of €1.51B represents 5.1x FCF, leverage limits flexibility.
Profitability & Returns
Revenue (TTM)
€2.39B
▼ -0.6% YoY
Net Income (TTM)
€69M
▼ -37.1% YoY
Op. Margin
8.39%
▼ -2.0pp YoY
ROIC
5.00%
▼ -1.8pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
€297M
▼ -2.7% YoY
Op. Cash Flow (TTM)
€345M
▼ -9.5% YoY
Net Debt
€1.51B
Cash & Equiv.
€309M
3Y CAGR: +4.2%
3Y CAGR: -4.8%
Continue Research